Wei Lin - Mar 21, 2024 Form 3 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
Chief Medical Officer
Signature
/s/ Jack Anders, as Attorney-in-fact for Wei Lin
Stock symbol
RVMD
Transactions as of
Mar 21, 2024
Transactions value $
$0
Form type
3
Date filed
3/29/2024, 04:57 PM
Previous filing
Jun 15, 2023
Next filing
Jun 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RVMD Common Stock 74.4K Mar 21, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RVMD Stock Option (Right to Buy) Mar 21, 2024 Common Stock 200K $23.85 Direct F2
holding RVMD Stock Option (Right to Buy) Mar 21, 2024 Common Stock 64.4K $29.80 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 74,400 Restricted Stock Units.
F2 Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 24, 2023 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
F3 One forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.